Authors: Koziol, JA Wagner, S Sobel, DF Slivka, LS Romine, JS Sipe, JC Adams, HP

Citation: Ja. Koziol et al., Predictive value of lesions for relapses in relapsing-remitting multiple sclerosis, AM J NEUROR, 22(2), 2001, pp. 284-291

Authors: Wagner, S Adams, HP Sobel, DF Slivka, LS Sipe, JC Romine, JS Koziol, JA

Citation: S. Wagner et al., New hypointense lesions on MRI in relapsing-remitting multiple sclerosis patients, EUR NEUROL, 43(4), 2000, pp. 194-200

Authors: Romine, JS Sipe, JC Koziol, JA Zyroff, J Beutler, E

Citation: Js. Romine et al., A double-blind, placebo-controlled, randomized trial of cladribine in relapsing-remitting multiple sclerosis, P ASS AM PH, 111(1), 1999, pp. 35-44

Authors: Sipe, JC Filippi, M Martino, G Furlan, R Rocca, MA Rovaris, M Bergami, A Zyroff, J Scotti, G Comi, G

Citation: Jc. Sipe et al., Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents, MAGN RES IM, 17(10), 1999, pp. 1521-1523

Authors: Koziol, JA Lucero, A Sipe, JC Romine, JS Beutler, E

Citation: Ja. Koziol et al., Responsiveness of the Scripps neurologic rating scale during a multiple sclerosis clinical trial, CAN J NEUR, 26(4), 1999, pp. 283-289

Authors: Adams, HP Wagner, S Sobel, DF Slivka, LS Sipe, JC Romine, JS Beutler, E Koziol, JA

Citation: Hp. Adams et al., Hypointense and hyperintense lesions on magnetic resonance imaging in secondary-progressive MS patients, EUR NEUROL, 42(1), 1999, pp. 52-63